Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
7.74M
-
Number of holders
-
10
-
Total shares
-
237K
-
Shares change
-
-52.5K
-
Total reported value, excl. options
-
$236K
-
Value change
-
-$50.3K
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$1.00
Significant Holders of Kazia Therapeutics Limited - American Depositary Shares (KZIA) as of Q3 2023
9 filings reported holding KZIA - Kazia Therapeutics Limited - American Depositary Shares as of Q3 2023.
Kazia Therapeutics Limited - American Depositary Shares (KZIA) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 237K shares
of 7.74M outstanding shares and own 3.06% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (190K shares), ACADIAN ASSET MANAGEMENT LLC (18.7K shares), Virtu Financial LLC (11.6K shares), BNP PARIBAS ARBITRAGE, SNC (8.5K shares), RHUMBLINE ADVISERS (7.56K shares), NewEdge Advisors, LLC (500 shares), BANK OF AMERICA CORP /DE/ (200 shares), Allworth Financial LP (87 shares), Steward Partners Investment Advisory, LLC (25 shares), and AdvisorNet Financial, Inc (5 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.